These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4106558)

  • 21. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
    Zorrilla E
    Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
    Heller H
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1035-8. PubMed ID: 4114489
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 25. Our experience with sequential estrogen-progestin treatments to inhibit ovulation.
    Cittadini E; Quartararo P; Romano F
    Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and morphological studies on hormonal contraception with the sequential method].
    Fettig O; Kopecky P
    Geburtshilfe Frauenheilkd; 1968 Jun; 28(6):540-53. PubMed ID: 4098858
    [No Abstract]   [Full Text] [Related]  

  • 27. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 29. [Towards a more physiological hormonal contraception].
    Stĕrba R
    Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cholestatic icterus after intake of ovulation inhibitors].
    Pansold E; Fischer I; Pfeifer K
    Dtsch Gesundheitsw; 1974 Mar; 29(10):470-5. PubMed ID: 4142434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Testing of an anti-conception drug: pure gestagen (chlormadinone acetate) in continually low dose].
    Jeppsson S; Kullander S
    Lakartidningen; 1969 Sep; 66(39):3949-55. PubMed ID: 4192490
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
    Rościszewska D
    Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nonanouvlatory doses of sequential mestranol-chlormadinone combination in female acne].
    Romiti N
    An Bras Dermatol; 1971; 46(1):13-8. PubMed ID: 4108151
    [No Abstract]   [Full Text] [Related]  

  • 34. [Migraine and hormonal contraceptives].
    Grässler W; Olthoff KH
    Z Arztl Fortbild (Jena); 1984; 78(6):229-32. PubMed ID: 6203234
    [No Abstract]   [Full Text] [Related]  

  • 35. [Has low-dosage therapy with the oral contraceptive Ovosiston any effect on glucose tolerance and liver function?].
    Heller H; Canzler E
    Z Gesamte Inn Med; 1970 Oct; 25(20):936-40. PubMed ID: 4106958
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral contraceptives, hypertension, and toxemia.
    Carmichael SM; Taylor MM; Ayers CR
    Obstet Gynecol; 1970 Mar; 35(3):371-6. PubMed ID: 4190423
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 38. Some apparently common problems in patients receiving contraceptive pills.
    Ball P
    Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
    [No Abstract]   [Full Text] [Related]  

  • 39. [Our experiences in the inhibition of undesired lactation using Ovosiston].
    Kosowski I; Iliew D
    Zentralbl Gynakol; 1972 Aug; 94(34):1134-6. PubMed ID: 4116879
    [No Abstract]   [Full Text] [Related]  

  • 40. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive.
    Karrer MC; Smith ER
    Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.